Combined topical composition dispenser/applicator and cap
Latest Bristol-Myers Squibb Company Patents:
- Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
- Substituted thienopyrroles as PAD4 inhibitors
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
FIG. 1 is a perspective view of our new design of a combined topical composition dispenser/applicator and cap;
FIG. 2 is a front elevational view thereof, the undisclosed rear elevational view being a mirror image;
FIG. 3 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 4 is a top plan view thereof;
FIG. 5 is a bottom plan view thereof;
FIG. 6 is an exploded front elevational view of the dispenser/applicator and cap illustrated in FIG. 2;
FIG. 7 is a top plan view of the dispenser/applicator thereof;
FIG. 8 is a bottom plan view of the cap thereof;
FIG. 9 is a perspective view of a modified embodiment of that illustrated in FIG. 1;
FIG. 10 is a front elevational view of the embodiment of FIG. 9, the undisclosed rear elevational view being a mirror image;
FIG. 11 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 12 is a top plan view thereof;
FIG. 13 is a bottom plan view thereof;
FIG. 14 is an exploded front elevational view of the modified dispenser/applicator and cap illustrated in FIG. 10;
FIG. 15 is a top plan view of the dispenser/applicator thereof;
FIG. 16 is a bottom plan view of the cap thereof; and,
FIG. 17 is a front elevational view of a modified embodiment of that illustrated in FIGS. 1 and 9.
Type: Grant
Filed: Jul 1, 1996
Date of Patent: Nov 4, 1997
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: John Sokol (Bridgewater, NJ), Kenneth Lang (Apex, NC), Curt Altmann (Darien, CT)
Primary Examiner: Martie Thompson
Attorney: Anthony M. Santini
Application Number: 0/56,471
International Classification: 0901;